Researching the impact of PCV10 on childhood pneumonia and pneumococcal disease protection in Kenya.

The Pneumococcal Conjugate Vaccine Impact Study (PCVIS) is one of the first population-level studies looking at the impact of a 10-valent Pneumococcal Conjugate Vaccine (PCV10) program on childhood pneumonia and pneumococcal disease protection in a lower-middle income country.